Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015 the Board of our company had approved the Unaudited Financial Results for the Quarter ended 30th June, 2025. The approved Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chennai Meenakshi Multispeciality Hospital announced its unaudited results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations stood at ₹864.90 lakhs, down 5.7% from ₹916.79 lakhs in the previous quarter and 1.1% lower than ₹874.74 lakhs in Q1 FY25. Total expenses rose to ₹967.47 lakhs, pushing the company to a net loss of ₹74.11 lakhs, almost double the ₹38.29 lakh loss posted in the same quarter last year and a sharp reversal from the ₹31.29 lakh profit in Q4 FY25. Basic EPS was in the red at (₹0.99). Accumulated reserves remained deeply negative at (₹935.62 lakhs), reflecting sustained past losses. Additionally, the Board appointed Mr. Edward M Prabhakar and Mr. Akash Prabhakar as Additional Directors effective August 13, 2025.
Widening quarterly losses, declining revenue, and deeply negative reserves point to ongoing financial stress and may weigh on the stock. However, this is a small, thinly-traded hospital stock, so the impact is likely muted except for existing shareholders watching fundamentals deteriorate.